The one-shot Johnson & Johnson vaccines have started to be delivered to the European Union on Monday, the first of 55 million doses which are expected to be provided to the bloc before the end of June.
EU Commission spokesman Stefan De Keersmaecker said the Johnson & Johnson deliveries “are indeed on track as agreed.”
About 105 million vaccine doses were delivered in the first quarter, a bitter disappointment since Anglo-Swedish company AstraZeneca fell about 90 million doses short of an initial commitment of 120 million. The other doses were delivered by Pfizer-BioNTech and Moderna with 65 million and 10 million doses respectively.
In the second quarter the EU is counting on 200 million doses of Pfizer-BioNTech, 35 million of Moderna, 70 million from AstraZeneca and 55 million from Johnson & Johnson.
The EU, with a population of 450 million, hopes to have 70 percent of its adults vaccinated by the end of summer.
Because it relies only on one shot, the Johnson & Johnson jabs are a key component of the EU’s vaccine strategy.